Cost recovery is a federal government policy intended to promote more business-like and equitable management of government programs. The policy stipulates that specific individuals or firms, who benefit directly from or cause government activity should bear some or all of the cost of those activities.

Many of Health Canada's regulatory activities represent a direct benefit to or are triggered by companies selling therapeutic products on the Canadian market; therefore, these activities are considered appropriate for cost recovery.

Fees for the Right to Sell Drugs

Master File Fees

Establishment Licence Fees

Submission Evaluation Fees

Cost Recovery Initiative

In April 2011, the Health Products and Food Branch (HPFB) updated user fees for the human drugs and medical devices regulatory programs, as part of its Cost Recovery Initiative.

Building on and consistent with Health Canada policies and direction, the Cost Recovery Initiative's goal is to develop and implement a cost recovery framework to provide a long-term stable funding source for HPFB's regulatory activities.

Report a problem or mistake on this page
Please select all that apply:

Privacy statement

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: